The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Open accessAbstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“modeling studies performed on the mutational data have estimated that the timeline of multistep progression to invasive neoplasia in the pancreas likely spans multiple years and provides a theoretically wide window of opportunity for early detection27.”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [27]
In the citing paper
“Pancreatic tumours are highly heterogeneous, both within and between individuals.66,67”
From Early detection of pancreatic cancer (2020) · cites this paper as [67]
In the citing paper
“It is now appreciated that most clinically relevant solid tumors are highly heterogeneous at the phenotypic, physiologic, and genomic levels (13–15) and that they continue to evolve over time.”
From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationCore Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationMetastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Tibor Antal, A., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 827
Self-citationAdvanced pancreatic carcinoma: current treatment and future challenges
Stathis, A., & Moore, M. J. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.236 · Cited by 791
Signatures of mutation and selection in the cancer genome
Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707
Self-citationMaitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,006
HSP90 as a platform for the assembly of more effective cancer chemotherapy
Whitesell, L. J., & Lin, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.006 · Cited by 85
Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT
Dettmer, M. S., Schmitt, A. M., Steinert, H. C., Capper, D., Moch, H., Komminoth, P., & Perren, A. A. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0057 · Cited by 84
Eser, S., Messer, M., Eser, P., von Werder, A., Seidler, B., Bajbouj, M., Vogelmann, R., Meining, A. G., von Burstin, J., Algül, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100890108 · Cited by 86
Intratumor heterogeneity predicts metastasis of triple-negative breast cancer
Yang, F., Wang, Y., Li, Q., Cao, L., Sun, Z., Jin, J., Fang, H., Zhu, A., Li, Y., Zhang, W., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx071 · Cited by 86
Blank, A., ROBERTS, D. E., Dawson, H., Zlobec, I., & Lugli, A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00234 · Cited by 93
Niu, N., Lu, P., Yang, Y.-L., He, R., Zhang, L., Shi, J., Wu, J., Yang, M., Zhang, Z., Wang, L., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318362 · Cited by 86
Survival Among Patients With Pancreatic Cancer and Long-Standing or Recent-Onset Diabetes Mellitus
Yuan, C., Rubinson, D. A., Qian, Z. R., Wu, C. H., Kraft, P. L., Bao, Y., Ogino, S., Ng, K., Clancy, T. E., Swanson, R. S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.5688 · Cited by 87
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature
Ghatnekar, O., Andersson, R., Svensson, M., Persson, U., Ringdahl, U., Zeilon, P., & Borrebaeck, C. A. K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28256 · Cited by 85
Refinement of screening for familial pancreatic cancer
Bartsch, D. K., Slater, E. P., Carrato, A., Ibrahim, I. S., Guillen-Ponce, C., Vasen, H. F. A., Matthäi, E., Earl, J., Jendryschek, F. S., Figiel, J., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311098 · Cited by 85
Wang, G., Yao, H., Gong, Y., Lu, Z., Pang, R., Li, Y., Yuan, Y., Song, H., Liu, J., Jin, Y., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2724 · Cited by 86
Evolutionary histories of breast cancer and related clones
Nishimura, T., Kakiuchi, N., Yoshida, K., Sakurai, T., Kataoka, T. R., Kondoh, E., Chigusa, Y., Kawai, M., Sawada, M., Inoue, T., et al. (2023) · Nature · doi:10.1038/s41586-023-06333-9 · Cited by 85
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 87
Bijlsma, M. F., & van Laarhoven, H. W. M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9541-1 · Cited by 84
The challenge of intratumour heterogeneity in precision medicine
Seoane, J., & Mattos‐Arruda, L. D. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12240 · Cited by 85
Weight Loss, Diabetes, Fatigue, and Depression Preceding Pancreatic Cancer
Olson, S. H., Xu, Y., Herzog, K., Saldia, A., DeFilippis, E. M., Li, P. C.-W., Allen, P. J., O'Reilly, E. M., & Kurtz, R. C. (2015) · Pancreas · doi:10.1097/mpa.0000000000000590 · Cited by 85
Chekhun, V. F., Sd, S., & Zd, S. (1985) · PubMed · Cited by 84
Gharibi, A., Kim, S. L., Molnar, J., Brambilla, D., Adamian, Y., Hoover, M. Y., Hong, J., Lin, J., Wolfenden, L., & Kelber, J. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-09946-z · Cited by 84
Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1–Dependent Immune Evasion
Yang, Y., Stang, A., Schweickert, P. G., Lanman, N. A., Paul, E. N., Monia, B. P., Revenko, A. S., Palumbo, J. S., Mullins, E. S., Elzey, B. D., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3206 · Cited by 84
Evolution of metastasis: new tools and insights
Gui, P., & Bivona, T. G. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.11.002 · Cited by 85
Al‐Kateb, H., Nguyen, T. T., Steger-May, K., & Pfeifer, J. D. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.05.004 · Cited by 84
Yabar, C. S., & Winter, J. M. (2016) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.04.003 · Cited by 85
Dynamics of targeted cancer therapy
Božić, I., Allen, B., & Nowak, M. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.006 · Cited by 86
Self-citationDarwinian evolution and tiding clones in multiple myeloma
Bahlis, N. J. (2012) · Blood · doi:10.1182/blood-2012-06-430645 · Cited by 82
Role of CYB5A in Pancreatic Cancer Prognosis and Autophagy Modulation
Giovannetti, E., Wang, Q., Avan, A., Funel, N., Lagerweij, T., Lee, J., Caretti, V., van der Velde, A., Boggi, U., Wang, Y., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt346 · Cited by 82
Cancer stem cells as ‘units of selection’
Greaves, M. F. (2012) · Evolutionary Applications · doi:10.1111/eva.12017 · Cited by 85
Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies
Roy, R., Zurakowski, D., Wischhusen, J., Frauenhoffer, C., Hooshmand, S. M., Kulke, M. H., & Moses, M. A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.462 · Cited by 82
Precursor lesions in pancreatic cancer: morphological and molecular pathology
Scarlett, C. J., Salisbury, E., Biankin, A. V., & Kench, J. G. (2011) · Pathology · doi:10.1097/pat.0b013e3283445e3a · Cited by 85
A framework for how environment contributes to cancer risk
Hochberg, M., & Noble, R. (2017) · Ecology Letters · doi:10.1111/ele.12726 · Cited by 86
Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy
Ascierto, M. L., Makohon-Moore, A. P., Lipson, E. J., Taube, J. M., McMiller, T. L., Berger, A. E., Fan, J., Kaunitz, G. J., Cottrell, T. R., Kohutek, Z. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0270 · Cited by 84
Self-citationToshima, F., Watanabe, R., Inoue, D., Yoneda, N., Yamamoto, T., Sasahira, N., Sasaki, T., Matsuyama, M., Minehiro, K., Tateishi, U., et al. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.21.26014 · Cited by 81
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs
Uppal, A., Ferguson, M. K., Posner, M. C., Hellmän, S., Khodarev, N. N., & Weichselbaum, R. R. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9664-3 · Cited by 81
Precancerous lesions of the pancreas
Zamboni, G., Hirabayashi, K., Castelli, P., & Lennon, A. M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.04.001 · Cited by 83
Nesprins in health and disease
Cartwright, S., & Karakesisoglou, I. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.12.010 · Cited by 79
Patel, M. B., Pothula, S. P., Xu, Z., Lee, A. K., Goldstein, D., Pirola, R. C., Apte, M. V., & Wilson, J. S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu122 · Cited by 81
Genomic and transcriptomic plasticity in treatment-naïve ovarian cancerPreprint
Hoogstraat, M., de Pagter, M. S., Cirkel, G. A., van Roosmalen, M. J., Harkins, T. T., Duran, K. J., Kreeftmeijer, J., Renkens, I., Witteveen, P. O., Lee, C. C., et al. (2013) · Genome Research · doi:10.1101/gr.161026.113 · Cited by 81
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Tang, D., Kroemer, G., & Kang, R. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01422-7 · Cited by 80
Advances in pancreatic cancer research: Moving towards early detection
He, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11241 · Cited by 80
Metabolism and Its Sequelae in Cancer Evolution and Therapy
Gillies, R. J., & Gatenby, R. A. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000102 · Cited by 80
Molecular pathways in pancreatic carcinogenesis
Macgregor‐Das, A. M., & Iacobuzio–Donahue, C. A. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23213 · Cited by 80
Self-citationCT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
Qi, C., Xie, T., Zhou, J., Wang, X., Gong, J., Zhang, X., Li, J., Yuan, J., Liu, C., & Shen, L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01491-9 · Cited by 80
A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data
Li, B., & Li, J. Z. (2014) · Genome biology · doi:10.1186/s13059-014-0473-4 · Cited by 76
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
Hidalgo, M. M., & Hoff, D. D. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1327 · Cited by 81
Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge
Hung, S. W., Mody, H. R., & Govindarajan, R. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.007 · Cited by 79
Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells
Takahashi, K., Ehata, S., Koinuma, D., Morishita, Y., Soda, M., Mano, H., & Miyazono, K. (2018) · Oncogene · doi:10.1038/s41388-018-0144-0 · Cited by 79
Characterizing Mutational Heterogeneity in a Glioblastoma Patient with Double Recurrence
Nickel, G. C., Barnholtz‐Sloan, J. S., Gould, M. P., McMahon, S., Cohen, A. J., Adams, M. D., Guda, K., Cohen, M. L., Sloan, A. E., & LaFramboise, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035262 · Cited by 79
Neoantigen-based cancer immunotherapy
Bobisse, S., Foukas, P. G., Coukos, G., & Harari, A. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.06.17 · Cited by 80
Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
Zhang, X., Shi, S., Zhang, B., Ni, Q., Yu, X., & Xu, J. (2018) · PubMed Central · Cited by 78
Dhaheri, Y. A., Attoub, S., Arafat, K., AbuQamar, S. F., Viallet, J. P., Saleh, A. I., Agha, H. A., Eid, A. H., & Iratni, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068808 · Cited by 80
Genetic Progression of Pancreatic Cancer
Cowan, R. W., & Maitra, A. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000011 · Cited by 76
Failure Patterns in Resected Pancreas Adenocarcinoma
Winter, J. M., Tang, L. H., Klimstra, D. S., Liu, W., Linkov, I., Brennan, M. F., D'Angelica, M. I., DeMatteo, R. P., Fong, Y., Jarnagin, W. R., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827fe9ce · Cited by 77
Exact solution of a two-type branching process: models of tumor progression
Tibor Antal, A., & Krapivsky, P. L. (2011) · Journal of Statistical Mechanics Theory and Experiment · doi:10.1088/1742-5468/2011/08/p08018 · Cited by 74
Brooks, P. J., & Zakhari, S. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01888.x · Cited by 78
Are liquid biopsies a surrogate for tissue EGFR testing?
Goldman, J. W., Noor, Z. S., Remón, J., Besse, B., & Rosenfeld, N. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx706 · Cited by 77
Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
Gall, T., Belete, S. C., Khanderia, E., Frampton, A. E., & Jiao, L. R. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.020 · Cited by 78
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
Noorani, A., Li, X., Goddard, M. J., Crawte, J., Alexandrov, L. B., Secrier, M., Eldridge, M., Bower, L., Weaver, J. M. J., Lao-Sirieix, P., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0551-3 · Cited by 75
Yang, J., Lin, P., Yang, M., Liu, W. C., Fu, X., Liu, D., Tao, L., Huo, Y., Zhang, J., Hua, R., et al. (2021) · Genome biology · doi:10.1186/s13059-020-02222-w · Cited by 76
Carrière, C., Young, A. L., Gunn, J. R., Longnecker, D. S., & Korc, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027725 · Cited by 77
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions
Neeße, A., Hahnenkamp, A., Griesmann, H., Buchholz, M., Hahn, S. A., Maghnouj, A., Fendrich, V., Ring, J., Sipos, B., Tuveson, D. A., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302577 · Cited by 77
Kumar, A., Boyle, E. A., Tokita, M., Mikheev, A. M., Sanger, M. C., Girard, E. J., Silber, J. R., Gonzalez‐Cuyar, L. F., Hiatt, J. B., Adey, A., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0530-z · Cited by 76
Abbas, A. I. A., Zenati, M. S., Reiser, C. J., Hamad, A. B., Jung, J. P., Zureikat, A. H., Zeh, H. J., & Hogg, M. E. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08156-3 · Cited by 77
Clonality and Evolutionary History of Rhabdomyosarcoma
Chen, L., Shern, J. F., Wei, J. S., Yohe, M. E., Song, Y., Hurd, L., Liao, H., Catchpoole, D. R., Skapek, S. X., Barr, F. G., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005075 · Cited by 77
Hu, C., Yang, D., Wang, Z., Huang, P., Wang, X., Chen, D., Cui, D., Yang, M., & Jia, N. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.09.035 · Cited by 76
Structural mutations in cancer: mechanistic and functional insights
Inaki, K., & Liu, E. T. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.07.002 · Cited by 75
Goswami, R. S., Patel, K. P., Singh, R. R., Meric‐Bernstam, F., Kopetz, S., Subbiah, V., Álvarez, R. H., Davies, M. A., Jabbar, K. J., Roy‐Chowdhuri, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2391 · Cited by 75
Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects
Griewank, K., Scolyer, R. A., Thompson, J. F., Flaherty, K. T., Schadendorf, D., & Murali, R. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt435 · Cited by 77
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
Menini, S., Iacobini, C., Vitale, M., Pesce, C. M., & Pugliese, G. (2021) · Cancers · doi:10.3390/cancers13020313 · Cited by 79
Verduzco, D., Lloyd, M. C., Xu, L., Ibrahim‐Hashim, A., Balagurunathan, Y., Gatenby, R. A., & Gillies, R. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120958 · Cited by 75
Current Knowledge on Pancreatic Cancer
Iovanna, J., Mallmann, M. C., Gonçalvès, A., Turrini, O., & Dagorn, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00006 · Cited by 74
Advances for studying clonal evolution in cancer
Ding, L., Raphael, B. J., Chen, F., & Wendl, M. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.12.028 · Cited by 74
Huerta, M., Roselló, S., Sabater-Orti, L., Ferrer, A., Tarazona, N., Roda, D., Gambardella, V., Alfaro‐Cervelló, C., Garcés‐Albir, M., Cervantes, A. M. R., et al. (2021) · Cancers · doi:10.3390/cancers13050994 · Cited by 78
Rafalko, J. M., Kruglyak, K. M., McCleary‐Wheeler, A. L., Goyal, V., Phelps‐Dunn, A., Wong, L. K., Warren, C. D., Brandstetter, G., Rosentel, M. C., DiMarzio, L. R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280795 · Cited by 82
Breast cancer intratumor genetic heterogeneity: causes and implications
Ng, C. K. Y., Pemberton, H. N., & Reis-Filho, J. S. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.85 · Cited by 77
Tumor progression: Chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution
Huang, S. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.05.001 · Cited by 83
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer
Mengelbier, L. H., Karlsson, J., Lindgren, D., Valind, A., Lilljebjörn, H., Jansson, C., Bexell, D., Braekeveldt, N., Ameur, A., Jonson, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms7125 · Cited by 74
Kwon, M.-C., Proost, N., Song, J., Sutherland, K. D., Zevenhoven, J., & Berns, A. J. M. (2015) · Genes & Development · doi:10.1101/gad.262998.115 · Cited by 74
Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait HallmarksPreprint
Fortunato, A., Boddy, A., Mallo, D., Aktipis, A., Maley, C. C., & Pepper, J. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029652 · Cited by 82
Woodcock, D. J., Рябченко, Е. В., Taavitsainen, S., Kankainen, M., Gundem, G., Brewer, D. S., Ellonen, P., Lepistö, M., Golubeva, Y. A., Warner, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18843-5 · Cited by 71
Matthaei, H., Hong, S., Mayo, S. C., Molin, M. D., Olino, K. L., Venkat, R., Goggins, M., Herman, J. M., Edil, B. H., Wolfgang, C. L., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1745-9 · Cited by 73
Self-citationGenome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing
Liang, W. S., Craig, D. W., Carpten, J. D., Borad, M. J., Demeure, M. J., Weiss, G. J., Izatt, T., Sinari, S. A., Christoforides, A., Aldrich, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043192 · Cited by 73
GLP1 and cancer: friend or foe?
Vangoitsenhoven, R., Mathieu, C., & der Schueren, B. V. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0111 · Cited by 77
Bria, E., Pilotto, S., Amato, E., Fassan, M., Novello, S., Peretti, U., Vavalà, T., Kinspergher, S., Righi, L., Santo, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3727 · Cited by 74
Lee, J. Y., Park, K., Kim, H. S., Kim, H. S., Yoo, K. H., Jung, K. S., Hong, M. E., Hong, M., Do, I., Ahn, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6192 · Cited by 72
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer
Krüger, S., Haas, M., Burger, P. J., Ormanns, S., Modest, D. P., Westphalen, C. B., Michl, M., Kleespies, A., Angele, M. K., Hartwig, W., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.016 · Cited by 75
Germline mutations in Japanese familial pancreatic cancer patients
Takai, E., Yachida, S., Shimizu, K., Furuse, J., Kubo, E., Ohmoto, A., Suzuki, M., Hruban, R. H., Okusaka, T., Morizane, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12490 · Cited by 73
Self-citationHeterogeneity and Targeting of Pancreatic Cancer Stem Cells
Penchev, V. R., Rasheed, Z. A., Maitra, A., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3112 · Cited by 72
What can molecular pathology contribute to the management of renal cell carcinoma?
Stewart, G. D., O’Mahony, F. C., Powles, T. B., Riddick, A. C. P., Harrison, D. J., & Faratian, D. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.43 · Cited by 71
Case–Control Study of Aspirin Use and Risk of Pancreatic Cancer
Streicher, S. A., Yu, H., Lu, L., Kidd, M. S., & Risch, H. A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1284 · Cited by 72
Pancreatic adenocarcinoma pathology: changing "landscape".
Brosens, L. A. A., Hackeng, W. M., Offerhaus, G. J. A., Hruban, R. H., & Wood, L. D. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.032 · Cited by 73
Self-citationMorphological heterogeneity in ductal adenocarcinoma of the pancreas – Does it matter?
Verbeke, C. S. (2016) · Pancreatology · doi:10.1016/j.pan.2016.02.004 · Cited by 72
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
Muzumdar, M. D., Dorans, K. J., Chung, K. M., Robbins, R., Tammela, T., Gocheva, V., Li, C. M.-C., & Jacks, T. (2016) · Nature Communications · doi:10.1038/ncomms12685 · Cited by 72
Fokas, E., O’Neill, E., Gordon-Weeks, A. N., Mukherjee, S., McKenna, W. G., & Muschel, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.12.001 · Cited by 75
The pancreatic cancer microenvironment: A true double agent
Melstrom, L. G., Salazar, M. D., & Diamond, D. J. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24643 · Cited by 74
Zheng, C., Fang, Y., Tong, W., Li, G., Wu, H., Zhou, W., Lin, Q., Yang, F., Yang, Z., Wang, P., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401117t · Cited by 72
Oligometastasis and oligo-recurrence: more than a mirage
Huang, F., Wu, G., & Yang, K. (2014) · Radiation Oncology · doi:10.1186/preaccept-1257312301290358 · Cited by 71
Machine Learning and Radiogenomics: Lessons Learned and Future Directions
Kang, J., Rancati, T., Lee, S., Oh, J. H., Kerns, S. L., Scott, J. G., Schwartz, R. S., Kim, S. Y., & Rosenstein, B. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00228 · Cited by 74
Soluble stroma‐related biomarkers of pancreatic cancer
Resovi, A., Bani, M. R., Porcu, L., Anastasia, A., Minoli, L., Allavena, P., Cappello, P., Novelli, F., Scarpa, A., Morandi, E., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708741 · Cited by 74
Winter, J. M., Jiang, W., Basturk, O., Mino-Kenudson, M., Fong, Z. V., Tan, W. P., Lavu, H., Vollmer, C. M., Furth, E. E., Haviland, D., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001319 · Cited by 73
New insights into pancreatic cancer biology
Hidalgo, M. M. (2012) · Annals of Oncology · doi:10.1093/annonc/mds313 · Cited by 71
Shannan, B., Perego, M., Somasundaram, R., & Herlyn, M. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-22539-5_1 · Cited by 70
Pishvaian, M. J., Bender, R. J., Matrisian, L. M., Rahib, L., Hendifar, A. E., Hoos, W. A., Mikhail, S., Chung, V. M., Picozzi, V. J., Heartwell, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13225 · Cited by 70
Metadata
- Authors
- Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Iacobuzio-Donahue, C. A.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- ORCID
- Venue
- Nature
- Published
- 2010-10
- Volume
- 467
- Issue
- 7319
- Pages
- 1114-1117
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3148940
- OpenAlex
- W2169895148
- Cited by
- 2,502
- References
- 24
- Citations by year
- 2026: 73 · 2025: 84 · 2024: 76 · 2023: 105 · 2022: 122 · 2021: 165 · 2020: 157 · 2019: 147 · 2018: 176 · 2017: 218 · 2016: 208 · 2015: 237 · 2014: 224 · 2013: 182 · 2012: 197
- FWCI
- 50.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01ca121113-15)
- U.S. Public Health Service (A62924)
- National Cancer Institute (R01CA140599, CA 57345, R01-CA121113, CA-121113, CA43460, K08CA106610, R37CA043460, R01CA057345, CA106610, P50CA062924, R37CA057345)
- National Institute of General Medical Sciences (R01GM078986, GM078986)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- pancreatic cancer, distant metastasis, clonal evolution, tumor subclones, chromosomal rearrangements, genomic instability, early detection, tumor heterogeneity, therapeutic target
- MeSH terms
- Adenocarcinoma, Autopsy, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Models, Biological, Mutation, Neoplasm Metastasis, Pancreas, Pancreatic Neoplasms, Peritoneal Neoplasms, Time Factors, Disease Progression, Cell Lineage, Evolution, Molecular, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
